Report Description
A recent market
intelligence report that is published by Data Insights Partner on the global Artificial
Pancreas market makes an offering of in-depth analysis of
segments and sub-segments in the regional and international Artificial
Pancreas market. The research also emphasizes on the impact
of restraints, drivers, and macro indicators on the regional and global Artificial
Pancreas market over the short as
well as long period of time. A detailed presentation of forecast, trends, and
dollar values of global Artificial Pancreas market is offered. In accordance with the report, the global Artificial
Pancreas market is projected to expand at a CAGR of 15% over the period of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
The pancreas
is an organ which secrets several hormones as well as digestive enzymes which
breaks down the food. Insulin assists cells to take up sugar from blood and use
for energy which reduces blood glucose levels. On the other hand, glucagon
assists the liver to release stored glucose which increases blood glucose
level. The artificial pancreas (automated insulin delivery) is a medical device
which stimulates the glucose regulating function of normal pancreas and reduces
incidence of low blood glucose. An artificial pancreas consists of glucose
monitoring system, and insulin infusion system- a blood glucose device is used
to calibrate continuous glucose monitoring system.
The global Artificial
Pancreas market is primarily driven by the growing population of diabetes, and
increasing adoption of self-administered insulin across worldwide. Conversely,
unavailability of artificial pancreas in developing countries, and higher cost
of artificial pancreas would likely to restrain the global Artificial Pancreas market
during the forecast period. However, technological advancement and new product
development, strategic alliance among key companies will provide the global
Artificial Pancreas market to provide an opportunity to propel in the upcoming
future. Medtronic, a reputed medical device received the FDA approval of
MiniMed 670G hybrid closed loop system in 2016. The company submitted a request
to the FDA for pre-market approval (PMA) for non-adjunctive labelling for
Guardian sensor 3, part of MiniMed 670G System in May 2019.
Segment Covered:
This market
intelligence report on the global Artificial Pancreas market encompasses market
segments based on type and end user. On the basis of type, the sub-market is control
to range systems, and control to target systems. Based on end user, the global Artificial
Pancreas market has been segregated into hospitals and ambulatory surgery
centers, clinics and others. By Geography, the global Artificial Pancreas market
has been divided into North America (the U.S., Canada), Latin America (Brazil,
Mexico, Argentina and other countries), Europe (Germany, France, the U.K.,
Spain, Italy, Russia, and other countries), Asia Pacific (India, Japan, China,
Australia and New Zealand and other countries), Middle East and Africa (GCC,
South Africa, Israel and Other countries).
Profiling of Market
Players:
This business
intelligence report offers profiling of reputed companies that are operating in
the market. Companies such as Medtronic, Johnson and Johnson Services, Inc., F.
HOFFMANN-LA ROCHE LTD, Insulet Corporation, Tandem Diabetes Care, Inc, Beta
Bionics, BIGFOOT BIOMEDICAL, INC, Inreda Diabetic B.V., etc. have been profiled
into detail so as to offer a glimpse of the market leaders. Moreover,
parameters such as Artificial Pancreas related investment & spending and
developments by major players of the market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid picture of the factors that are steering and restraining the
growth of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is also provided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis has
been used in this report to present a clear picture of the market. The study
focuses on the present market trends and provides market forecast from the year
2017-2027. Emerging trends that would shape the market demand in the years to
come have been highlighted in this report. A competitive analysis in each of
the geographical segments gives an insight into market share of the global
players.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the Artificial
Pancreas market, size of the
market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of
forecast: 2019 – 2027, taking into account 2018 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, launch of new products, competitive market strategies of
leading market players, emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Artificial Pancreas market is done by taking into account various parameters such as
company strategies, distribution strategies, product portfolio, financial
performance, key developments, geographical presence, and company overview
Ø
Leading
market players covered this report comprise names such as Medtronic, Johnson and Johnson Services, Inc., F.
HOFFMANN-LA ROCHE LTD, Insulet Corporation, Tandem Diabetes Care, Inc, Beta Bionics, BIGFOOT BIOMEDICAL, INC, Inreda
Diabetic B.V., and among others
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of products, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world
market for Artificial Pancreas caters to the needs
of various stakeholders pertaining to this industry, namely suppliers, manufacturers,
investors, and distributors for Artificial Pancreas market. The research also caters to the rising needs of consulting
and research firms, financial analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the
investment opportunities in the Artificial
Pancreas market
v
Identification
of key factors driving investment opportunities in the Artificial Pancreas market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants